Press Releases

Date Title and Summary Additional Formats
02/20/19 Phibro Animal Health Corporation to Participate in Bank of America Merrill Lynch 2019 Animal Health Summit
TEANECK, N.J. , Feb. 20, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) announced it will participate in the Bank of America Merrill Lynch 2019 Animal Health Summit being held at the Bank of America Tower in New York . Chairman, President and Chief Executive Officer Jack
View HTML
02/11/19 Phibro Animal Health Introduces Provia™ Prime
Direct-Fed Microbial Solution to Help Promote Health , Immunity and Weight Gain in Poultry TEANECK, N.J. --(BUSINESS WIRE)--Feb. 11, 2019-- During the 2019 IPPE show, Phibro Animal Health will introduce its new Provia™ Prime direct fed microbial product that helps optimize the gut microbiome for
View HTML
02/06/19 Phibro Animal Health Corporation Declares Quarterly Dividend
TEANECK, N.J. , Feb. 06, 2019 (GLOBE NEWSWIRE) -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 27, 2019 , to stockholders of record at the
View HTML
02/06/19 Phibro Animal Health Corporation Reports Second Quarter Results
TEANECK, N.J. , Feb. 06, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its second quarter ended December 31, 2018 . Highlights for the December 2018 quarter (compared to the December 2017 quarter) Net sales of $218 million , an
View HTML
01/28/19 Phibro Animal Health Corporation to Participate in Bank of America Merrill Lynch 2019 Animal Health Summit
TEANECK, N.J. , Jan. 28, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) Chairman, President and Chief Executive Officer Jack Bendheim , Chief Financial Officer Richard Johnson and Executive Vice President, Corporate Strategy Daniel Bendheim will address financial analysts
View HTML
01/09/19 Canada Approves Phibro Solution for Beef Cattle
Teaneck, New Jersey (January 9, 2019) – V-Max™ (Virginiamycin) medicated feed additive has received regulatory approval by the Veterinary Drugs Directorate (VDD), Health Canada for use in beef cattle. V-Max is approved for the reduction of incidence of liver abscesses in cattle fed in confinement, which is a condition that affects the well-being of an estimated one in five feedlot cattle in Canada. 
01/02/19 Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2018 Quarterly Financial Results
TEANECK, N.J. , Jan. 02, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) expects to announce its second quarter financial results on Wednesday, February 6, 2019 , after the market closes. Phibro management will host a conference call and webcast on Thursday, February 7, 2019
View HTML
12/20/18 Phibro Animal Health Works with Dr. Lon Whitlow on Preventing, Recognizing and Mitigating Mycotoxin Contamination
Knowledge is Power Preventing, Recognizing and Mitigating Mycotoxin Contamination By Lon W. Whitlow , Professor Emeritus, Animal Science, North Carolina State University TEANECK, N.J. --(BUSINESS WIRE)--Dec. 20, 2018-- What is often present, is worsened by oxygen and becomes more noticeable over
View HTML
12/06/18 Aquaculture Acquisition to Create Vaccine Innovation Powerhouse
Phibro Animal Health Acquires Fish Vaccine Business of KoVax TEL AVIV, Israel , Dec. 06, 2018 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) today announced it has acquired the assets of KoVax Ltd. , an Israel -based developer and manufacturer of vaccines for the global
View HTML
11/06/18 Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance
TEANECK, N.J. , Nov. 06, 2018 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) today announced its financial results for its first quarter ended September 30, 2018 , and presented updated financial guidance for the fiscal year. Highlights for the September 2018 quarter (compared
View HTML